Related Experiment Videos
Isolated ultrafiltration in moderate congestive heart failure
P G Agostoni1, G C Marenzi, M Pepi
1Istituto di Cardiologia dell' Università degli Studi, Milan, Italy.
Journal of the American College of Cardiology
|February 1, 1993
Summary
Ultrafiltration significantly improves exercise capacity and reduces symptoms in patients with moderate congestive heart failure. This intervention offers a new therapeutic option for heart failure management.
Area of Science:
- Cardiology
- Nephrology
- Pulmonology
Background:
- Ultrafiltration is an established treatment for severe congestive heart failure.
- The efficacy in moderate congestive heart failure remains less understood.
Purpose of the Study:
- To assess the benefits of ultrafiltration in patients with moderate congestive heart failure (New York Heart Association functional classes II and III).
Main Methods:
- A randomized controlled trial involving 36 patients with moderate congestive heart failure.
- Eighteen patients underwent a single ultrafiltration session, while 18 served as controls.
- Hemodynamic parameters, lung function, and exercise capacity were monitored over a 6-month follow-up.
Main Results:
- Ultrafiltration led to significant reductions in right atrial pressure, pulmonary wedge pressure, and cardiac index immediately post-procedure.
- Improved lung function, decreased extravascular lung water, and increased peak oxygen consumption and anaerobic threshold were observed during follow-up.
- Enhanced exercise performance correlated with favorable changes in norepinephrine levels and kinetics.
Conclusions:
- Ultrafiltration is beneficial in patients with moderate congestive heart failure.
- The procedure reduces the severity of the heart failure syndrome.
- Ultrafiltration improves hemodynamic status, exercise tolerance, and potentially neurohormonal balance.